MicroRNA-199b Downregulation Confers Resistance to 5-Fluorouracil Treatment and Predicts Poor Outcome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients

Neoadjuvant 5-fluorouracil (5-FU)-based chemoradiotherapy followed by mesorectal excision is the current standard treatment in locally advanced rectal cancer (LARC) and the lack of complete response represents a major problem that compromises long-term patient survival. However, there is a lack of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Cristóbal, Ion, Rubio, Jaime, Santos, Andrea, Torrejón, Blanca, Caramés, Cristina, Imedio, Laura, Mariblanca, Sofía, Luque, Melani, Sanz-Alvarez, Marta, Zazo, Sandra, Madoz-Gúrpide, Juan, Rojo, Federico, García-Foncillas, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352382/
https://www.ncbi.nlm.nih.gov/pubmed/32580513
http://dx.doi.org/10.3390/cancers12061655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352382/
https://www.ncbi.nlm.nih.gov/pubmed/32580513
http://dx.doi.org/10.3390/cancers12061655

Ejemplares similares